The role of metals in cardiovascular disease
Healy, M.A.; Aslam, M.
Nursing Times 79(2): 41-43
1983
ISSN/ISBN: 0954-7762 PMID: 6550278 Document Number: 215846
Document emailed within 1 workday
Related Documents
Mulvad, G.; Pedersen, H.S.; Hansen, J.C.; Dewailly, E.; Jul, E.; Pedersen, M.; Deguchi, Y.; Newman, W.P.; Malcom, G.T.; Tracy, R.E.; Middaugh, J.P.; Bjerregaard, P. 1996: The Inuit diet. Fatty acids and antioxidants, their role in ischemic heart disease, and exposure to organochlorines and heavy metals. An international study Arctic Medical Research 55 Suppl. 1: 20-24Tarasenko, N.I.; Vorob'eva, R.S.; Akinfieva, T.A. 1982: Cardiovascular system after exposure to various metals Vestnik Akademii Meditsinskikh Nauk SSSR 10: 59-63
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Wander, G.S.; Hukkeri, M.Yunus.Khan.; Yalagudri, S.; Mahajan, B.; Panda, A.Toppo. 2018: Rosuvastatin: Role in Secondary Prevention of Cardiovascular Disease Journal of the Association of Physicians of India 66(3): 70-74
Kostyukevich, M.V.; Zykov, K.A.; Mironova, N.A.; Agapova, O.Y.; Shevelev, A.Y.; Efremov, E.E.; Vlasik, T.N.; Golitsyn, S.P. 2016: Role of Autoantibodies Against 1-Adrenergic Receptor in Cardiovascular Disease Kardiologiia 56(12): 82-91
Kozłowska, A.; Kowalska, I. 2006: The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease Endokrynologia Polska 57(6): 626-632
Nordt, T.K.; Peter, K.; Ruef, J.; Kübler, W.; Bode, C. 1999: Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease Thrombosis and Haemostasis 82(Suppl 1): 14-18
Cosentino, F. 2003: Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation Recenti Progressi in Medicina 94(10): 444-450
Cannon, R.O. 1998: Role of nitric oxide in cardiovascular disease: focus on the endothelium Clinical Chemistry 44(8 Part 2): 1809-1819
Liew, D.; Krum, H. 2002: The role of aldosterone receptor blockade in the management of cardiovascular disease Current Opinion in Investigational Drugs 3(10): 1468-1473
Feener, E.P.; King, G.L. 2001: Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease Heart Failure Monitor 1(3): 74-82
Hu, F.B.. 2001: The role of n-3 polyunsaturated fatty acids in the prevention and treatment of cardiovascular disease Drugs of Today 37(1): 49-56
Li, L.-L.; Zhao, Z.-Q. 2013: The role and significance of microRNA in human cardiovascular disease and forensic science Fa Yi Xue Za Zhi 29(1): 39-42
Wright, I.S.; Fredrickson, D.T. 1971: Report of Inter-Society Commission for Heart Disease Resources. II. Cardiovascular Disease--acute care. Inter-relationship among health facilities-future role of modern communication and transportation Circulation 43(1): A97-A99
Weir, F.W.; Fabiano, V.L. 1982: Re-evaluation of the role of carbon monoxide in production or aggravation of cardiovascular disease processes Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 24(7): 519-525
Kravchun, P.; Kadykova, O.; Gabisoniia, T. 2012: The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease Georgian Medical News 213: 26-31
Clemetson, C.A. 1979: Some thoughts on the epidemiology of cardiovascular disease, (with special reference to women "on the pill"). Role of ascorbic acid Medical Hypotheses 5(8): 825-834
Schrager, S.; Dalby, J.; Hayon, R.; Fox, K. 2013: Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease Fp Essentials 411: 28-33
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Sluiter, W.; Pietersma, A.; Lamers, J.M.; Koster, J.F. 1993: Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression Journal of Cardiovascular Pharmacology 22(Suppl): S37-S44